|
WO2018068120A1
|
|
Use of a compound, synthetic intermediate, pharmaceutical composition, and neuromodulatory therapeutic method
|
|
BR102017010169A2
|
|
compound, synthesis intermediate, use in anticonvulsant preparation, anticonvulsant pharmaceutical composition
|
|
BR102016023848A2
|
|
ANTICONVULSANT, PHARMACEUTICAL USE AND COMPOSITION CONTAINING THE SAME
|
|
BR102014000521A2
|
|
peptide, pharmaceutical composition, in vitro and / or in vivo inhibition of cell division, in vitro cell identification method and uses
|
|
CN104619333A
|
|
Modified peptide, cb receptor ligand, kit, in vitro process for evaluating cb receptor bonds, uses, pharmaceutical composition for modulating cb receptor activity
|
|
EP2878306A1
|
|
Modified peptide, cb receptor ligand, kit, in vitro process for evaluating cb receptor bonds, uses, pharmaceutical composition for modulating cb receptor activity
|
